Cover Image

Comparing the cost-effectiveness of the MPT64-antigen detection test to Xpert MTB/RIF and ZN-microscopy for the diagnosis of Extrapulmonary Tuberculosis: An economic evaluation modelling study.

Extrapulmonary Tuberculosis (EPTB) poses challenges from patient and health system perspectives. The cost-effectiveness analysis of the Xpert MTB/RIF (Xpert) test to diagnose pulmonary tuberculosis is documented. However, there are no economic evaluations for EPTB. Considering the reported better di...

Full description

Saved in:

Bibliographic Details
Main Authors:	Shoaib Hassan (Author), Tehmina Mustafa (Author), William Muller (Author), Lisete Torres (Author), Msafiri Marijani (Author), Esther Ngadaya (Author), Sayoki Mfinanga (Author), Yakobo Lema (Author), Erlend Grønningen (Author), Melissa Jorstad (Author), Ole Norheim (Author), Bjarne Robberstad (Author)
Format:	Book
Published:	Public Library of Science (PLoS), 2024-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Improved diagnosis of extrapulmonary tuberculosis in adults with and without HIV in Mbeya, Tanzania using the MPT64 antigen detection test
by: Erlend Grønningen, et al.
Published: (2022)

Improved diagnosis of extrapulmonary tuberculosis in adults with and without HIV in Mbeya, Tanzania using the MPT64 antigen detection test.
by: Erlend Grønningen, et al.
Published: (2022)

Xpert® MTB/RIF assay on formalin-fixed paraffin-embedded tissues in the diagnosis of extrapulmonary tuberculosis
by: Allan N. Njau, et al.
Published: (2019)

Diagnostic accuracy of Xpert MTB/RIF and Xpert ultra tests in pulmonary and extrapulmonary tuberculosis compared to Löwenstein-Jensen culture
by: Miguel Hueda-Zavaleta, et al.
Published: (2024)

Evaluation of Xpert MTB/RIF Ultra for the Diagnosis of Extrapulmonary Tuberculosis: A Retrospective Analysis in Saudi Arabia
by: Mousa J. Slail, et al.
Published: (2023)

Utilization of GeneXpert MTB/RIF in the Southern Department of Haiti
by: T. Kedia, et al.
Published: (2015)

Use of Xpert MTB/RIF for diagnosis of pediatric tuberculosis in Indonesia
by: Rina Triasih, et al.
Published: (2020)

Xpert MTB/RIF versus sputum microscopy as the initial diagnostic test for tuberculosis: a cluster-randomised trial embedded in South African roll-out of Xpert MTB/RIF
by: Dr. Gavin J Churchyard, PhD, et al.
Published: (2015)

Validation and implementation of GeneXpert MTB/RIF for diagnosis of Tuberculosis in Ecuador
by: José Marcelo Ortíz-Jimenes, et al.
Published: (2019)

Development of dried tube specimens for Xpert MTB/RIF proficiency testing
by: Kyle DeGruy, et al.
Published: (2020)

Cost-effectiveness of Xpert MTB/RIF and investing in health care in Africa
by: Keertan Dheda, et al.
Published: (2014)

Cost-effectiveness of Xpert MTB/RIF and investing in health care in Africa
by: Ivor Langley, et al.
Published: (2015)

Performance of Xpert® MTB/RIF among tuberculosis outpatients in Lilongwe, Malawi
by: Tarsizio Chikaonda, et al.
Published: (2017)

Operational lessons drawn from pilot implementation of Xpert MTB/Rif in Brazil
by: Betina Durovni, et al.
Published: (2014)

Xpert MTB/RIF: a game changer for the diagnosis of pulmonary tuberculosis in children?
by: Annelies Van Rie
Published: (2013)

Diagnosis of cutaneous tuberculosis (lymph node scrofuloderma) using the Xpert MTB/RIF® method,
by: Lilian Lemos Costa, et al.
Published: (2021)

Xpert MTB/RIF for tuberculosis testing: access and price in highly privatised health markets
by: Lekha Puri, et al.
Published: (2016)

Evaluation of the GeneXpert MTB/RIF to diagnose tuberculosis in a public health laboratory
by: Mohanna Damasceno Arbués, et al.
Published: (2024)

Xpert MTB/RIF Ultra for Tuberculosis Testing in Children: A Mini-Review and Commentary
by: Rachel R. Atherton, et al.
Published: (2019)

Pooling sputum for Xpert MTB/RIF and Xpert Ultra testing during the Covid-19 pandemic in Lao People's Democratic Republic.
by: Vibol Iem, et al.
Published: (2022)

Pooling sputum for Xpert MTB/RIF and Xpert Ultra testing during the Covid-19 pandemic in Lao People's Democratic Republic
by: Vibol Iem, et al.
Published: (2022)

Utility of Xpert MTB/RIF Assay for Diagnosis of Pediatric Tuberculosis Under Programmatic Conditions in India
by: Rakesh Yadav, et al.
Published: (2020)

Challenges with scale-up of GeneXpert MTB/RIF® in Uganda: a health systems perspective
by: Talemwa Nalugwa, et al.
Published: (2020)

New TB Tools Need to be Affordable in the Private Sector: The Case Study of Xpert MTB/RIF
by: Nirros Ponnudurai, et al.
Published: (2018)

A Model of Tuberculosis Screening for Pregnant Women in Resource-Limited Settings Using Xpert MTB/RIF
by: Eleanor R. Turnbull, et al.
Published: (2012)

Rolling out Xpert MTB/RIF® for tuberculosis detection in HIV-positive populations: An opportunity for systems strengthening
by: Ishani Pathmanathan, et al.
Published: (2017)

Estimating the effect of a rifampicin resistant tuberculosis diagnosis by the Xpert MTB/RIF assay on two-year mortality
by: Elise De Vos, et al.
Published: (2023)

False rifampicin resistant results using Xpert MTB/RIF on urine samples in hospitalised HIV-infected patients
by: Charlotte Schutz, et al.
Published: (2019)

Retrospective observational study to compare Xpert MTB/RIF assay with other diagnostic tests in lymph node tuberculosis
by: Nithya Haridas, et al.
Published: (2022)

A global proficiency testing programme for Xpert® MTB/RIF using dried tube specimens, 2013-2015
by: Katherine Klein, et al.
Published: (2020)

Investigation of OMNIgene·SPUTUM performance in delayed tuberculosis testing by smear, culture, and Xpert MTB/RIF assays in Uganda
by: C.D. Kelly-Cirino, et al.
Published: (2019)

Establishing the cost of Xpert MTB/RIF mobile testing in high-burden peri-mining communities in South Africa
by: Naseem Cassim, et al.
Published: (2021)

Validación e implementación de GeneXpert MTB/RIF para diagnóstico de tuberculosis en Ecuador
by: Ortiz-Jiménez, José Marcelo, et al.
Published: (2019)

Impact of the GeneXpert® MTB/RIF rapid molecular test on tuberculosis detection: temporal trends and vulnerable territories
by: Thaís Zamboni Berra, et al.

Stool Xpert MTB/RIF as a possible diagnostic alternative to sputum in Africa: a systematic review and meta-analysis
by: Francesco Vladimiro Segala, et al.
Published: (2023)

Analysis of Xpert MTB/RIF results in retested patients with very low initial bacterial loads: A retrospective study in China
by: Jun Wang, et al.
Published: (2023)

Assessment of the patient, health system, and population effects of Xpert MTB/RIF and alternative diagnostics for tuberculosis in Tanzania: an integrated modelling approach
by: Ivor Langley, MSc, et al.
Published: (2014)

Effectiveness of Xpert MTB/RIF and the Line Probe Assay tests for the rapid detection of drug-resistant tuberculosis in the Central African Republic.
by: Alain Farra, et al.
Published: (2023)

Impact of Xpert MTB/RIF and decentralized care on linkage to care and drug-resistant tuberculosis treatment outcomes in Johannesburg, South Africa
by: Denise Evans, et al.
Published: (2018)

Impact of Xpert MTB/RIF on Outcomes of Adults Hospitalized With Spinal Tuberculosis: Findings From a Comparative Cohort in Beijing, China
by: Jun Fan, et al.
Published: (2022)